Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Healthcare Medical Devices

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Add To Watchlist

Recent & Breaking News (NYSE:ABT)

Abbott Acknowledged by Science Magazine as a Top Employer

PR Newswire October 16, 2014

Abbott Celebrates the Power of Health and Achievement as First-Ever Title Sponsor of World Marathon Majors

Canada NewsWire October 10, 2014

Abbott Goes Extra Mile in Commitment to Helping People Live Healthy Lives as an Official Sponsor of 2014 Bank of America Chicago Marathon

PR Newswire October 1, 2014

Abbott Hosts Conference Call for Third-Quarter Earnings

PR Newswire October 1, 2014

Abbott Completes Acquisition of CFR Pharmaceuticals; Announces Results of Tender Offer for CFR Shares

PR Newswire September 26, 2014

Expiration of the U.S. Tender Offer for CFR Pharmaceuticals S.A.

PR Newswire September 24, 2014

Abbott Included In Top 10 Best Companies by Working Mother Magazine

PR Newswire September 16, 2014

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

PR Newswire September 15, 2014

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

PR Newswire September 14, 2014

Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend

PR Newswire September 11, 2014

Abbott Once Again Named the Industry Leader for Responsible and Sustainable Business on the Dow Jones Sustainability Index (DJSI)

PR Newswire September 11, 2014

New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs

PR Newswire September 8, 2014

Abbott Receives CE Mark for FreeStyle® Libre, a Revolutionary Glucose Monitoring System for People with Diabetes

PR Newswire September 3, 2014

Abbott Commences Tender Offer for All Outstanding Ordinary Shares and American Depositary Shares of CFR Pharmaceuticals S.A.

PR Newswire August 25, 2014

Abbott Joins Forces with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions

PR Newswire August 18, 2014

Access to Abbott's MitraClip® System Expands in the U.S. with Medicare National Coverage Determination

PR Newswire August 12, 2014

Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo

PR Newswire July 28, 2014

Abbott Introduces New Similac® Breastfeeding Supplement with DHA, Lutein and Vitamin E

PR Newswire July 24, 2014

Abbott Reports Second-Quarter 2014 Results

PR Newswire July 16, 2014

Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan

Canada NewsWire July 14, 2014